Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.15 HKD | +0.18% | +6.26% | -0.55% |
Jul. 04 | Ascentage Grants Takeda Exclusive Option for Licensing of Blood Cancer Drug | MT |
Jun. 21 | Ascentage Pharma Group Completes $75 Million Share Subscription Deal with Takeda International | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.55% | 1.07B | |
+18.43% | 122B | |
+19.81% | 112B | |
-23.74% | 19.33B | |
-18.45% | 16.17B | |
-19.97% | 15.6B | |
-49.33% | 14.65B | |
+57.08% | 14.34B | |
+7.95% | 14B | |
+126.04% | 11.29B |
- Stock Market
- Equities
- 6855 Stock
- News Ascentage Pharma Group International
- Ascentage Pharma to Present Preclinical Results of Three Anti-Tumor Drugs at US Cancer Meet